Xavier Calvet
#162,788
Most Influential Person Now
Researcher
Xavier Calvet's AcademicInfluence.com Rankings
Xavier Calvetcomputer-science Degrees
Computer Science
#9502
World Rank
#9976
Historical Rank
Computational Linguistics
#2306
World Rank
#2329
Historical Rank
Machine Learning
#4174
World Rank
#4223
Historical Rank
Artificial Intelligence
#4520
World Rank
#4582
Historical Rank
Download Badge
Computer Science
Xavier Calvet's Degrees
- Masters Artificial Intelligence Stanford University
- Bachelors Computer Science University of California, Berkeley
Similar Degrees You Can Earn
Why Is Xavier Calvet Influential?
(Suggest an Edit or Addition)Xavier Calvet's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- PREVALENCE OF ANTIBODIES TO HEPATITIS C VIRUS IN SPANISH PATIENTS WITH HEPATOCELLULAR CARCINOMA AND HEPATIC CIRRHOSIS (1989) (739)
- Time Trends and Impact of Upper and Lower Gastrointestinal Bleeding and Perforation in Clinical Practice (2009) (515)
- Addition of a second endoscopic treatment following epinephrine injection improves outcome in high-risk bleeding ulcers. (2004) (276)
- Meta‐analysis: role of Helicobacter pylori eradication in the prevention of peptic ulcer in NSAID users (2005) (239)
- Management of Nonvariceal Upper Gastrointestinal Bleeding: Guideline Recommendations From the International Consensus Group (2019) (232)
- Prognostic factors of hepatocellular carcinoma in the west: A multivariate analysis in 206 patients (1990) (225)
- Sequential Therapy for Helicobacter pylori Eradication: A Critical Review (2010) (223)
- Optimum duration of regimens for Helicobacter pylori eradication. (2013) (216)
- Risk of upper and lower gastrointestinal bleeding in patients taking nonsteroidal anti-inflammatory drugs, antiplatelet agents, or anticoagulants. (2015) (209)
- Safety of Thiopurines and Anti-TNF-α Drugs During Pregnancy in Patients With Inflammatory Bowel Disease (2013) (206)
- Epinephrine injection versus epinephrine injection and a second endoscopic method in high risk bleeding ulcers. (2014) (190)
- Proton pump inhibitor, clarithromycin and either amoxycillin or nitroimidazole: a meta‐analysis of eradication of Helicobacter pylori (2000) (181)
- Liver dysfunction related to hepatitis B and C in patients with inflammatory bowel disease treated with immunosuppressive therapy (2010) (174)
- Review article: rifabutin in the treatment of refractory Helicobacter pylori infection (2012) (173)
- Meta‐analysis: esomeprazole or rabeprazole vs. first‐generation pump inhibitors in the treatment of Helicobacter pylori infection (2012) (170)
- Review article: non‐bismuth quadruple (concomitant) therapy for eradication of Helicobater pylori (2011) (169)
- Proton pump inhibitors versus H2‐antagonists: a meta‐analysis of their efficacy in treating bleeding peptic ulcer (2001) (147)
- The changing face of hospitalisation due to gastrointestinal bleeding and perforation (2011) (143)
- Prevalence and Factors Related to Hepatitis B and C in Inflammatory Bowel Disease Patients in Spain: A Nationwide, Multicenter Study (2009) (142)
- Triple vs. quadruple therapy for treating Helicobacter pylori infection: an updated meta‐analysis (2003) (141)
- Single vs. double dose of a proton pump inhibitor in triple therapy for Helicobacter pylori eradication: a meta‐analysis (2002) (140)
- Meta‐analysis: high‐dose proton pump inhibitors vs. standard dose in triple therapy for Helicobacter pylori eradication (2008) (134)
- Diagnosis and Epidemiology of Helicobacter pylori Infection (2013) (131)
- Randomised clinical trial comparing sequential and concomitant therapies for Helicobacter pylori eradication in routine clinical practice (2013) (128)
- Natural history of hepatocellular carcinoma in Spain. Five year's experience in 249 cases. (1990) (127)
- Review article: Helicobacter pylori‐negative duodenal ulcer disease (2009) (120)
- Identification of factors that influence tolerance of upper gastrointestinal endoscopy. (1999) (117)
- Meta‐analysis: comparative efficacy of different proton‐pump inhibitors in triple therapy for Helicobacter pylori eradication (2003) (115)
- Review article: the effectiveness of standard triple therapy for Helicobacter pylori has not changed over the last decade, but it is not good enough (2011) (115)
- Systematic review and meta-analysis: susceptibility-guided versus empirical antibiotic treatment for Helicobacter pylori infection. (2015) (115)
- Update on non-bismuth quadruple (concomitant) therapy for eradication of Helicobacter pylori (2012) (114)
- Infliximab salvage therapy after failure of ciclosporin in corticosteroid‐refractory ulcerative colitis: a multicentre study (2012) (109)
- ‘Rescue’ Therapy with Rifabutin after Multiple Helicobacter pylori Treatment Failures (2003) (108)
- Helicobacter pylori eradication therapy vs. antisecretory non‐eradication therapy (with or without long‐term maintenance antisecretory therapy) for the prevention of recurrent bleeding from peptic ulcer (2004) (103)
- Hepatitis C virus infection in patients with nonalcoholic chronic liver disease. (1990) (103)
- Factors predicting failure of endoscopic injection therapy in bleeding duodenal ulcer. (1996) (102)
- Second-Line Rescue Therapy With Levofloxacin After H. pylori Treatment Failure: A Spanish Multicenter Study of 300 Patients (2008) (99)
- Prevalence of Malnutrition and Nutritional Characteristics of Patients With Inflammatory Bowel Disease (2017) (99)
- Ten-Day Sequential Treatment for Helicobacter pylori Eradication in Clinical Practice (2008) (99)
- Cancer antigen 125 in serum and ascitic fluid of patients with liver diseases. (1991) (98)
- Accuracy of diagnostic tests for Helicobacter pylori: a reappraisal. (2009) (95)
- Meta‐analysis: predictors of rebleeding after endoscopic treatment for bleeding peptic ulcer (2011) (94)
- Delphi consensus statement: Quality Indicators for Inflammatory Bowel Disease Comprehensive Care Units. (2014) (93)
- Factors related to the failure of endoscopic injection therapy for bleeding gastric ulcer. (1996) (88)
- Meta-analysis: Helicobacter pylori eradication therapy vs. antisecretory non-eradication therapy for the prevention of recurrent bleeding from peptic ulcer. (2004) (88)
- Has H. pylori Prevalence in Bleeding Peptic Ulcer Been Underestimated? A Meta-Regression (2011) (88)
- Evolution After Anti-TNF Discontinuation in Patients With Inflammatory Bowel Disease: A Multicenter Long-Term Follow-Up Study (2017) (86)
- Observational study on the efficacy of adalimumab for the treatment of ulcerative colitis and predictors of outcome. (2013) (84)
- Helicobacter pylori eradication therapy vs. antisecretory non‐eradication therapy for the prevention of recurrent bleeding from peptic ulcer (2004) (81)
- Phase II study of transarterial embolization in european patients with hepatocellular carcinoma: Need for controlled trials (1994) (79)
- Diagnosis of Helicobacter pylori Infection (2010) (78)
- How and When Should NSAIDs Be Used for Preventing Post-ERCP Pancreatitis? A Systematic Review and Meta-Analysis (2013) (77)
- Systematic Review and Meta‐analysis: Proton Pump Inhibitor vs. Ranitidine Bismuth Citrate Plus Two Antibiotics in Helicobacter pylori Eradication (2005) (77)
- Helicobacter pylori infection is a protective factor for bleeding gastric ulcers but not for bleeding duodenal ulcers in NSAID users (2000) (76)
- Long-Term Follow-Up of 1,000 Patients Cured of Helicobacter pylori Infection Following an Episode of Peptic Ulcer Bleeding (2012) (73)
- Triple vs. quadruple therapy for treating Helicobacter pylori infection: a meta‐analysis (2003) (72)
- Seven versus Ten Days of Rabeprazole Triple Therapy for Helicobacter pylori Eradication: A Multicenter Randomized Trial (2005) (69)
- H. pylori eradication therapy vs. antisecretory non-eradication therapy (with or without long-term maintenance antisecretory therapy) for the prevention of recurrent bleeding from peptic ulcer. (2003) (68)
- Fourth‐line rescue therapy with rifabutin in patients with three Helicobacter pylori eradication failures (2012) (67)
- One‐week triple vs. quadruple therapy for Helicobacter pylori infection — a randomized trial (2002) (66)
- IV Spanish Consensus Conference on Helicobacter pylori infection treatment. (2016) (65)
- Real-Time PCR Improves Helicobacter pylori Detection in Patients with Peptic Ulcer Bleeding (2011) (65)
- Incidence, Clinical Characteristics, and Management of Psoriasis Induced by Anti-TNF Therapy in Patients with Inflammatory Bowel Disease: A Nationwide Cohort Study (2016) (65)
- Meta‐analysis: proton pump inhibitors vs. H2‐receptor antagonists — their efficacy with antibiotics in Helicobacter pylori eradication (2003) (65)
- Second-line Therapy With Levofloxacin After Failure of Treatment to Eradicate Helicobacter pylori Infection: Time Trends in a Spanish Multicenter Study of 1000 Patients (2013) (65)
- Helicobacter pylori is a risk factor for peptic ulcer disease in cirrhotic patients. A meta-analysis (2002) (63)
- Risk factors for hepatocellular carcinoma in catalonia, spain (1990) (58)
- Cost-Minimization Analysis Favours Intravenous Ferric Carboxymaltose over Ferric Sucrose for the Ambulatory Treatment of Severe Iron Deficiency (2012) (57)
- Variability in microRNA recovery from plasma: Comparison of five commercial kits. (2015) (57)
- Helicobacter Pylori “Test-and-Treat” Strategy for Management of Dyspepsia: A Comprehensive Review (2013) (55)
- Review article: common misconceptions in the management of Helicobacter pylori‐associated gastric MALT‐lymphoma (2011) (52)
- What is the optimal length of proton pump inhibitor‐based triple therapies for H. pylori? A cost‐effectiveness analysis (2001) (52)
- Plasma sample based analysis of gastric cancer progression using targeted metabolomics (2017) (51)
- Relevant infections in inflammatory bowel disease, their relationship with immunosuppressive therapy and their effects on disease mortality. (2019) (51)
- Adalimumab vs Azathioprine in the Prevention of Postoperative Crohn’s Disease Recurrence. A GETECCU Randomised Trial (2017) (51)
- Topical pharyngeal anesthesia improves tolerance of upper gastrointestinal endoscopy: a randomized double-blind study. (1995) (50)
- Phenotype and natural history of elderly onset inflammatory bowel disease: a multicentre, case‐control study (2018) (50)
- Epidemiology of peptic ulcer disease in cirrhotic patients: role of helicobacter pylori infection (1998) (50)
- Management of NSAID-associated peptic ulcer disease (2016) (48)
- Effectiveness of Adalimumab in Perianal Fistulas in Crohn’s Disease Patients Naive to Anti-TNF Therapy (2015) (48)
- Fatigue in out-patients with inflammatory bowel disease: Prevalence and predictive factors (2017) (47)
- Seroprevalence and epidemiology of Helicobacter pylori infection in patients with cirrhosis. (1997) (46)
- Long-Term Efficacy and Safety of Cyclosporine in a Cohort of Steroid-Refractory Acute Severe Ulcerative Colitis Patients from the ENEIDA Registry (1989–2013): A Nationwide Multicenter Study (2017) (46)
- Evaluation of three different tests for the detection of stool antigens to diagnose Helicobacter pylori infection in patients with upper gastrointestinal bleeding (2004) (45)
- Comparative accuracy of 3 monoclonal stool tests for diagnosis of Helicobacter pylori infection among patients with dyspepsia. (2010) (45)
- [Eradication treatment of Helicobacter pylori. Recommendations of the II Spanish Consensus Conference]. (2005) (44)
- Accuracy of Monoclonal Stool Tests for Determining Cure of Helicobacter pylori Infection After Treatment (2010) (43)
- Triple vs. quadruple therapy for treating Helicobacter pylori infection: a meta-analysis. (2003) (42)
- Remission on thiopurinic immunomodulators normalizes quality of life and psychological status in patients with Crohn's disease (2006) (41)
- Diagnostic Performance of the Simple Clinical Colitis Activity Index Self-Administered Online at Home by Patients With Ulcerative Colitis: CRONICA-UC Study (2016) (41)
- Adalimumab Maintenance Treatment in Ulcerative Colitis: Outcomes by Prior Anti-TNF Use and Efficacy of Dose Escalation (2017) (41)
- Usefulness of a delayed test for the diagnosis of Helicobacter pylori infection in bleeding peptic ulcer (2006) (40)
- Surgical resection and survival in Western patients with hepatocellular carcinoma. (1992) (40)
- Effect of ranitidine on gastric intramucosal pH in critically ill patients (1998) (39)
- Systematic review: third-line susceptibility-guided treatment for Helicobacter pylori infection (2016) (38)
- [Treatment for the eradication of Helicobacter pylori. Recommendations of the Spanish Consensus Conference]. (2000) (37)
- Pantoprazole based therapies in Helicobacter pylori eradication: a systematic review and meta-analysis (2004) (37)
- microRNA profiling in duodenal ulcer disease caused by Helicobacter pylori infection in a Western population. (2012) (36)
- IBD-related work disability in the community: Prevalence, severity and predictive factors. A cross-sectional study (2015) (36)
- [III Spanish Consensus Conference on Helicobacter pylori infection]. (2013) (36)
- A new validation of the Spanish Work Productivity and Activity Impairment Questionnaire-Crohn's disease version. (2011) (35)
- A randomized study of the safety of outpatient care for patients with bleeding peptic ulcer treated by endoscopic injection. (2004) (35)
- Value and limitations of cytologic criteria for the diagnosis of hepatocellular carcinoma by fine needle aspiration biopsy. (1993) (35)
- Diagnostic accuracy of fine-needle aspiration biopsy in patients with hepatocellular carcinoma (1989) (34)
- Technetium-99m DISIDA hepatobiliary agent in diagnosis of hepatocellular carcinoma: relationship between detectability and tumor differentiation. (1988) (33)
- Diagnosis of Helicobacter pylori Infection in the Proton Pump Inhibitor Era. (2015) (33)
- Ustekinumab versus adalimumab for induction and maintenance therapy in biologic-naive patients with moderately to severely active Crohn's disease: a multicentre, randomised, double-blind, parallel-group, phase 3b trial (2022) (33)
- Increased risk of thiopurine‐related adverse events in elderly patients with IBD (2019) (32)
- Rabeprazole‐based therapies in Helicobacter pylori eradication (2003) (31)
- Cost-minimization analysis favours intravenous ferric carboxymaltose over ferric sucrose or oral iron as preoperative treatment in patients with colon cancer and iron deficiency anaemia. (2016) (31)
- Usefulness of endoscopic band ligation for bleeding small bowel vascular lesions. (2003) (31)
- Diagnostic accuracy of three monoclonal stool tests in a large series of untreated Helicobacter pylori infected patients. (2016) (31)
- Usefulness of Non‐invasive Tests for Diagnosing Helicobacter pylori Infection in Patients Undergoing Dialysis for Chronic Renal Failure (2004) (30)
- High‐dose, ten‐day esomeprazole, amoxicillin and metronidazole triple therapy achieves high Helicobacter pylori eradication rates (2012) (30)
- Effectiveness and Safety of the Sequential Use of a Second and Third Anti-TNF Agent in Patients With Inflammatory Bowel Disease: Results From the Eneida Registry. (2019) (30)
- Tuberculosis in Anti-Tumour Necrosis Factor-treated Inflammatory Bowel Disease Patients After the Implementation of Preventive Measures: Compliance With Recommendations and Safety of Retreatment. (2016) (30)
- Systematic review and meta-analysis: triple therapy combining a proton-pump inhibitor, amoxicillin and metronidazole for Helicobacter pylori first-line treatment. (2016) (29)
- Urticarial reaction to oral polyethylene glycol electrolyte lavage solution. (1992) (29)
- Real‐world long‐term effectiveness of ustekinumab in Crohn's disease: results from the ENEIDA registry (2020) (29)
- Metabolomic Analysis of Gastric Cancer Progression within the Correa's Cascade Using Ultraperformance Liquid Chromatography-Mass Spectrometry. (2016) (28)
- Systematic review: Rabeprazole-based therapies in Helicobacter pylori eradication. (2003) (27)
- Evaluation of Helicobacter pylori diagnostic methods in patients with liver cirrhosis (2002) (27)
- Risk of colectomy in patients with ulcerative colitis under thiopurine treatment. (2014) (27)
- Infliximab Maintenance Therapy Is Associated With Decreases in Direct Resource Use in Patients With Luminal or Fistulizing Crohn's Disease (2009) (27)
- Two‐week dual vs. one‐week triple therapy for cure of Helicobacter pylori infection in primary care: a multicentre, randomized trial (1999) (26)
- Usefulness of oral beclometasone dipropionate in the treatment of active ulcerative colitis in clinical practice: the RECLICU Study. (2010) (26)
- The sequential therapy regimen for Helicobacter pylori eradication (2010) (25)
- Eradication of Helicobacter pylori for the Prevention of Peptic Ulcer Rebleeding (2007) (25)
- [Guidelines for the diagnosis and treatment of acute non-variceal upper gastrointestinal bleeding]. (2003) (25)
- Development and validation of the Crohn's disease perceived work disability questionnaire (2011) (25)
- Impact of treatment with direct-acting antivirals on anxiety and depression in chronic hepatitis C (2018) (25)
- Helicobacter pylori is not a risk factor for hepatic encephalopathy. (2001) (24)
- Disease severity in familial cases of IBD. (2014) (24)
- Repeated Neostigmine Dosage as Palliative Treatment for Chronic Colonic Pseudo-Obstruction in a Patient With Autonomic Paraneoplastic Neuropathy (2003) (24)
- Diagnosis of Helicobacter pylori infection in dyspeptic patients by stool antigen detection usefulness of a new monoclonal enzyme immunoassay test. (2004) (24)
- Extracolonic Cancer in Inflammatory Bowel Disease: Data from the GETECCU Eneida Registry (2017) (24)
- Comparison of Two Management Strategies for Helicobacter pylori Treatment: Clinical Study and Cost‐effectiveness Analysis (2005) (24)
- Post‐Operative Morbidity and Mortality of a Cohort of Steroid Refractory Acute Severe Ulcerative Colitis: Nationwide Multicenter Study of the GETECCU ENEIDA Registry (2018) (24)
- What is Potent Acid Inhibition, and How Can it be Achieved? (2012) (24)
- Clinical characteristics, associated malignancies and management of primary sclerosing cholangitis in inflammatory bowel disease patients: A multicenter retrospective cohort study. (2019) (23)
- Two-day quadruple therapy for cure of helicobacter pylori infection: a comparative, randomized trial (1998) (23)
- Effectiveness and safety of the switch from Remicade to CT-P13 in patients with inflammatory bowel disease. (2019) (23)
- Limited usefulness of a seven‐day twice‐a‐day quadruple therapy (2000) (21)
- Effect of sucralfate on gastric intramucosal pH in critically ill patients (1997) (21)
- Correlation Between Anti-TNF Serum Levels and Endoscopic Inflammation in Inflammatory Bowel Disease Patients (2018) (20)
- Helicobacter pylori Infection: Treatment Options (2006) (19)
- Evaluation of Four Different Fecal Tests for Determination of Cure After Helicobacter pylori Treatment (2006) (19)
- Efficacy of low and standard midazolam doses for gastroscopy. A randomized, double‐blind study (2000) (18)
- [Fulminant infection caused by varicella herpes zoster in patient with Crohn disease undergoing treatment with azathioprine]. (2001) (18)
- Early Use of Azathioprine Has a Steroid Sparing Effect on Recently Diagnosed Crohn's Disease Patients (2011) (18)
- Systematic review: Would susceptibility‐guided treatment achieve acceptable cure rates for second‐line Helicobacter pylori therapy as currently practiced? (2019) (18)
- Stool antigen for the diagnosis of Helicobacter pylori infection in cirrhosis: comparative usefulness of three different methods (2003) (18)
- The Effects of Infliximab or Adalimumab on Vascular Endothelial Growth Factor and Angiopoietin 1 Angiogenic Factor Levels in Inflammatory Bowel Disease: Serial Observations in 37 Patients (2014) (18)
- [Seven-day omeprazole, clarithromycin, and amoxicillin for the therapy of Helicobacter pylori infection]. (1998) (18)
- Extraintestinal Manifestations in Patients with Inflammatory Bowel Disease: Study Based on the ENEIDA Registry (2020) (18)
- [The evaluation of a new immunoenzyme analysis for the detection of Helicobacter pylori infection in stool samples]. (1999) (17)
- Prospective evaluation of liver fibrosis in chronic viral hepatitis C infection using the Sabadell NIHCED (Non-Invasive Hepatitis-C-Related Cirrhosis Early Detection) index. (2009) (17)
- Perception of disease burden and treatment satisfaction in patients with ulcerative colitis from outpatient clinics in Spain: UC-LIFE survey (2016) (17)
- Effectiveness and safety of ustekinumab in ulcerative colitis: Real-world evidence from the ENEIDA registry (2021) (17)
- Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological Study (2021) (17)
- Four‐Day, Twice Daily, Quadruple Therapy with Amoxicillin, Clarithromycin, Tinidazole and Omeprazole to Cure Helicobacter pylori Infection: A Pilot Study (2000) (17)
- Safe prescription recommendations for non steroidal anti-inflammatory drugs: consensus document ellaborated by nominated experts of three scientific associations (SER-SEC-AEG). (2014) (17)
- Efficacy and safety of endoscopic balloon dilation in inflammatory bowel disease: results of the large multicenter study of the ENEIDA registry (2019) (17)
- Proton pump inhibitor versus ranitidine bismuth citrate plus two antibiotics for one week. A meta-analysis of its efficacy on Hericobacter pylori eradication (2000) (17)
- Perceived Emotional and Psychological Impact of Ulcerative Colitis on Outpatients in Spain: UC-LIFE Survey (2016) (16)
- Safe Prescription Recommendations for Non Steroidal Anti-inflammatory Drugs: Consensus Document Elaborated by Nominated Experts of Three Scientific Associations (SER-SEC-AEG) (2014) (16)
- Systematic review, meta‐analysis, and meta‐regression: Successful second‐line treatment for Helicobacter pylori (2018) (16)
- Proton pump inhibitors versus H2 antagonists. A meta-analysis of its efficacy on bleeding peptic ulcer (2001) (16)
- Validation of the Spanish Work Productivity and Activity impairment questionnaire: Crohn's disease version (2009) (16)
- Meta-analysis: comparative efficacy of H2-receptor antagonists and proton pump inhibitors for reducing aspiration risk during anaesthesia depending on the administration route and schedule. (2012) (16)
- Spanish primary care survey on the management of Helicobacter pylori infection and dyspepsia: Information, attitudes, and decisions (2019) (15)
- Bismuth quadruple regimen with tetracycline or doxycycline versus three‐in‐one single capsule as third‐line rescue therapy for Helicobacter pylori infection: Spanish data of the European Helicobacter pylori Registry (Hp‐EuReg) (2020) (15)
- [Evaluation of a rapid test (ImmunoCard STAT! HpSA) for Helicobacter pylori detection in stools]. (2003) (15)
- Diarrhea as a presenting symptom of hepatocellular carcinoma (1990) (15)
- [Clinical practice guideline on the management of patients with dyspepsia. Update 2012]. (2012) (14)
- Guide Regarding Choice of Second‐line Therapy to Obtain a High Cumulative Cure Rate (2012) (14)
- A Prospective Pilot Randomized Study: Electroacupuncture vs. Sham Procedure for the Treatment of Fatigue in Patients With Quiescent Inflammatory Bowel Disease. (2019) (14)
- Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) and the Association of Crohn's Disease and Ulcerative Colitis Patients (ACCU) in the management of psychological problems in Inflammatory Bowel Disease patients. (2018) (14)
- Good diagnostic accuracy of a chemiluminescent immunoassay in stool samples for diagnosis of Helicobacter pylori infection in patients with dyspepsia (2016) (14)
- Helicobacter pylori inactivation and virulence gene damage using a supported sensitiser for photodynamic therapy. (2013) (14)
- T1943 Is H. pylori Testing Clinically Useful in the Acute Setting of Upper Gastrointestinal Bleeding? a Systematic Review (2009) (14)
- Outcomes of peptic ulcer bleeding following treatment with proton pump inhibitors in routine clinical practice: 935 patients with high- or low-risk stigmata (2014) (13)
- Key Points for Designing and Reporting Helicobacter pylori Therapeutic Trials: A Personal View (2011) (13)
- [Sedation in digestive endoscopy. Results of a hospital survey in Catalonia (Spain)]. (2004) (13)
- Patients’ perceptions of the impact of ulcerative colitis on social and professional life: results from the UC-LIFE survey of outpatient clinics in Spain (2018) (13)
- Inflammatory bowel disease integral care units: Evaluation of a nationwide quality certification programme. The GETECCU experience (2021) (12)
- Dealing with uncertainty in the treatment of Helicobacter pylori (2018) (12)
- What is the best strategy for diagnosis and treatment of Helicobacter pylori in the prevention of recurrent peptic ulcer bleeding? A cost-effectiveness analysis. (2009) (12)
- Epinephrine injection versus epinephrine injection and a second endoscopic method in high-risk bleeding ulcers. (2014) (11)
- Validation of phone interview for follow‐up in clinical trials on dyspepsia: evaluation of the Glasgow Dyspepsia Severity Score and a Likert‐scale symptoms test (2000) (11)
- 7‐day rescue therapy with ranitidine bismuth citrate after Helicobacter pylori treatment failure (2005) (11)
- [Evaluation of Helicobacter pylori susceptibility to rifaximin]. (2004) (11)
- Variation among endoscopy units in the achievement of the standards of colonoscopic performance indicators. (2008) (10)
- Prevalence of Helicobacter pylori infection in the Vallès Occidental, Catalonia (1999) (10)
- Eradication of Helicobacter pylori for the prevention of peptic ulcer rebleeding (2008) (10)
- Effectiveness of anti-TNFα drugs in patients with Crohn's disease who do not achieve remission with their first anti-TNFα agent. (2016) (9)
- Expression profile of circulating microRNAs in the Correa pathway of progression to gastric cancer (2018) (9)
- Clinical trials in Helicobacter pyloriinfection (1998) (9)
- Dual Versus Endoscopic Monotherapy in Bleeding Peptic Ulcers (2007) (9)
- Analysis of the association between fatigue and the plasma lipidomic profile of inflammatory bowel disease patients. (2020) (9)
- Improving Quality of Care in Inflammatory Bowel Disease Through Patients' Eyes: IQCARO Project. (2020) (9)
- Fourteen‐day high‐dose esomeprazole, amoxicillin and metronidazole as third‐line treatment for Helicobacter pylori infection (2017) (9)
- Prevalence of severe esophagitis in Spain. Results of the PRESS study (Prevalence and Risk factors for Esophagitis in Spain: A cross-sectional study) (2016) (9)
- Seven-day versus 10- to 14-day therapies with a proton pump inhibitor, clarithromycin and either metronidazole or amoxicillin for treating Hericobacter pylori infection. A metaanalysis (2000) (9)
- [Safe prescription recommendations for non steroidal anti-inflammatory drugs: Consensus document ellaborated by nominated experts of three scientific associations (SER-SEC-AEG)]. (2014) (9)
- Idiopathic pylephlebitis and idiopathic sclerosing peritonitis in a man with protein S deficiency. (2001) (9)
- Modified seven-day, quadruple therapy as a first line Helicobacter pylori treatment. (2001) (8)
- Helicobacter pylori does not play a part in the dyspeptic complaints of rheumatology patients receiving long term treatment with non-steroidal anti-inflammatory drugs (2002) (8)
- Update on the management of Helicobacter pylori infection. Position paper from the Catalan Society of Digestology. (2018) (8)
- Changes in the requirement for early surgery in inflammatory bowel disease in the era of biological agents (2020) (8)
- Modified seven‐day, quadruple therapy as a first line Helicobacter pylori treatment (2001) (8)
- Genetic variation analysis in a follow‐up study of gastric cancer precursor lesions confirms the association of MUC2 variants with the evolution of the lesions and identifies a significant association with NFKB1 and CD14 (2018) (8)
- Outcome after a dose "de-intensification" strategy with anti-TNF drugs in patients with Crohn's disease. (2016) (8)
- Optimising Acid Inhibition Treatment (2012) (8)
- [Helicobacter pylori infection and functional dyspepsia. Meta-analysis of efficacy of eradication therapy]. (2002) (8)
- Occult H. pylori infection partially explains ‘false-positive’ results of 13C-urea breath test (2015) (8)
- [First Spanish consensus on peptic ulcer bleeding management. Consenso sobre Hemorragia Digestiva por Úlcera Péptica]. (2010) (8)
- Gastric ulcer penetrating to the liver: endoscopic diagnosis. (1993) (8)
- High-dose vs non-high-dose PPIs after endoscopic treatment in patients with bleeding peptic ulcer: current evidence is insufficient to claim equivalence. (2010) (8)
- Ranitidine–bismuth citrate, tetracycline and metronidazole followed by triple therapy as alternative strategy for Helicobacter pylori treatment: a pilot study (2004) (7)
- [Management of Helicobacter pylori infection in primary care in Spain]. (2008) (7)
- Development and Validation of the Short Crohn's Disease Work Disability Questionnaire (2016) (7)
- Droplet Digital PCR Detects Low-Density Infection in a Significant Proportion of Helicobacter Pylori-Negative Gastric Biopsies of Dyspeptic Patients (2020) (7)
- Prevalence, incidence and mortality of inflammatory bowel disease in Catalonia. A population-based analysis (2018) (7)
- Endoscopist’s Judgment Is as Useful as Risk Scores for Predicting Outcome in Peptic Ulcer Bleeding: A Multicenter Study (2020) (7)
- Gastric cancer screening in low incidence populations: Position statement of AEG, SEED and SEAP. (2020) (7)
- Analysis of court criteria for awarding disability benefits to patients with Crohn's disease. (2009) (6)
- Su1132 Toxicity and Mortality Related to the Use of Ciclosporin in Steroid Refractory Ulcerative Colitis: A Multicentric Nationwide Study (ENEIDA) (2013) (6)
- W1274 Efficacy and Safety of Infliximab Rescue Therapy After Cyclosporine Failure in Patients With Steroid-Refractory Ulcerative Colitis: A Multicenter Study (2010) (6)
- V Spanish Consensus Conference on Helicobacter pylori infection treatment. (2021) (6)
- Fendrix vs Engerix-B for Primo-Vaccination Against Hepatitis B Infection in Patients With Inflammatory Bowel Disease: A Randomized Clinical Trial. (2020) (6)
- Usefulness of Housekeeping Genes for the Diagnosis of Helicobacter pylori Infection, Strain Discrimination and Detection of Multiple Infection (2016) (6)
- [Gastroesophageal reflux disease: epidemiology, diagnosis and treatment]. (2008) (6)
- Sa1882 Phase IV, Prospective, Randomized and Comparative Study Between Sequential and Concomitant Therapy for Helicobacter pylori Eradication in Routine Clinical Practice (2013) (6)
- Portal pressure in patients with exudative ascites in the course of acute hepatitis B. (2008) (6)
- H. pylori eradication does not reduce paraprotein levels in monoclonal gammopathy of unknown significance (MGUS): a prospective cohort study (2009) (6)
- Time Trends of Crohn’s Disease in Catalonia from 2011 to 2017. Increasing Use of Biologics Correlates with a Reduced Need for Surgery (2020) (6)
- [Current management of nonvariceal upper gastrointestinal bleeding in Spain]. (2012) (6)
- V Spanish Consensus Conference on Helicobacter pylori infection treatment. (2017) (6)
- Prospective, study comparing the accuracy of two different stool antigen tests (Premier Platinum HpSA and novel ImmunoCard STAT! rapid test) for the diagnosis of Helicobacter pylori infection. (2019) (6)
- Diagnostic utility of nasogastric tube aspiration and the ratio of blood urea nitrogen to creatinine for distinguishing upper and lower gastrointestinal tract bleeding. (2018) (6)
- Prevalence of Helicobacter pylori resistance after failure of first-line therapy. A systematic review. (2018) (6)
- Fendrix vs Engerix-B for Primo-Vaccination Against Hepatitis B Infection in Patients With Inflammatory Bowel Disease: A Randomized Clinical Trial. (2020) (6)
- Equipment review: Gastric intramucosal pH measurement (1997) (5)
- Usefulness of indirect noninvasive methods in predicting progression to cirrhosis in chronic hepatitis C (2015) (5)
- [Testing a new in-office test for determination of faecal Helicobacter pylori antigen]. (2002) (5)
- [Helicobacter pylori does not contribute to iron deficiency in hemodialysis patients]. (2006) (5)
- Effectiveness and safety of methotrexate monotherapy in patients with Crohn’s disease refractory to anti‐TNF‐α: results from the ENEIDA registry (2021) (5)
- Could Increasing the Duration of Triple Therapy Be a Clinically Useful Strategy? (2008) (5)
- Gastric cancer screening in low incidence populations: Position statement of AEG, SEED and SEAP (2021) (5)
- Gastric Intramucosal pH Determination: Limitations of the Technique (1995) (5)
- High Effectiveness of a 14-Day Concomitant Therapy for Helicobacter pylori Treatment in Primary Care. An Observational Multicenter Study (2020) (4)
- Manejo de la hemorragia digestiva baja aguda: documento de posicionamiento de la Societat Catalana de Digestologia. (2013) (4)
- [Nasogastric intubation in patients with upper gastrointestinal bleeding?]. (2016) (4)
- [Helicobacter pylori eradication treatment in non-ulcerous disease]. (2005) (4)
- OP034 The initiation of thiopurines in elderly patients with inflammatory bowel disease is associated with an increased risk of adverse effects: a case–control study of the ENEIDA registry (2018) (4)
- [Therapeutic strategies in Helicobacter pylori infection]. (2001) (4)
- Utility of histology for the diagnosis of portal hypertensive gastroenteropathy. Concordance between the endoscopic image and gastrointestinal biopsies. Role of the CD34 marker. (2018) (4)
- Radiological diagnosis of inorganic lead poisoning. (1989) (4)
- Re: peppers at treatment for Helicobacter pylori infection (2000) (4)
- Inter and intra-observer concordance for the diagnosis of portal hypertension gastropathy. (2018) (4)
- Uptake of Technetium‐99m DISIDA by Bone Metastasis From a Hepatoma (1988) (4)
- Increased alphafetoprotein levels in hepatocellular carcinoma: The relationship with tumor size determines its limited value in early detection (1989) (4)
- Switching to a second thiopurine in adult and elderly patients with inflammatory bowel disease: a nationwide study from the ENEIDA registry. (2020) (4)
- Data on individual PCR efficiency values as quality control for circulating miRNAs (2015) (4)
- Effect of proton pump inhibitors on the outcomes of peptic ulcer bleeding: comparison of event rates in routine clinical practice and a clinical trial (2013) (4)
- M1115 Sequential Therapy for Helicobacter pylori Eradication: A Critical Review (2010) (4)
- Nasogastric intubation in patients with upper gastrointestinal bleeding (2016) (4)
- P391 The availability of anti-TNF agents is associated with reduced early surgical requirements in Crohn’s disease but not in ulcerative colitis. A nationwide study from the Eneida registry (2018) (3)
- Whole-Genome Sequencing and Comparative Genomics of Three Helicobacter pylori Strains Isolated from the Stomach of a Patient with Adenocarcinoma (2021) (3)
- Utility of histology for the diagnosis of portal hypertensive gastroenteropathy. Concordance between the endoscopic image and gastrointestinal biopsies. Role of the CD34 marker (2019) (3)
- A Nurse-Driven Outpatient Clinic for Thiopurine-Treated Inflammatory Bowel Disease Patients Reduces Physician Visits and Increases Follow-Up Efficiency (2015) (3)
- Tu1990 Correlation Between Anti-TNF Serum Levels and Mucosal Healing (MH) in Inflammatory Bowel Disease (IBD) Patient (2016) (3)
- Su1686 The Effectiveness of Standard Triple-Therapy for Helicobacter pylori Has Not Changed Over the Last Decade, but it is Not Good Enough (2012) (3)
- Effectiveness of a Dose “De-Escalation” Strategy With Anti-TNF Drugs in Patients With Crohn's Disease (CD) (2011) (3)
- Immune thrombocytopenic purpura associated with Crohn's disease with complete response to infliximab. (2019) (3)
- M1096 High Dose vs. Standard Dose Proton Pump Inhibitor Triple Therapy for Helicobacter pylori Eradication: A Meta-Analysis (2008) (3)
- Su1329 Evolution After Anti-TNF Drug Discontinuation in Patients With Inflammatory Bowel Disease (IBD): A Multicenter Long-Term Follow-Up Study (2015) (3)
- 113 Clinical Impact and Time Trends of Upper and Lower Gastrointestinal Complications (2008) (3)
- Letter: are idiopathic (non‐NSAID, non‐Helicobacter pylori) ulcers really increasing? (2012) (3)
- Letter: the irony of oral iron – not an underdog for post‐gastrointestinal bleeding anaemia (2014) (3)
- [Clinical practice guideline on the management of patients with dyspepsia. Update 2012]. (2012) (3)
- M1112 Eradication of Helicobacter pylori for the Prevention of Peptic Ulcer Rebleeding. Long-Term Follow-up Study of 800 Patients (2010) (3)
- [Management of dyspepsia, gastroduodenal ulcer and Helicobacter pylori infection in primary care]. (2002) (3)
- Corrigendum: Diagnostic Performance of the Simple Clinical Colitis Activity Index Self-Administered Online at Home by Patients With Ulcerative Colitis: CRONICA-UC Study (2016) (3)
- Manejo de la hemorragia digestiva alta no varicosa: documento de posicionamiento de la Societat Catalana de Digestologia (2017) (3)
- Selecting the Best Combined Biological Therapy for Refractory Inflammatory Bowel Disease Patients (2022) (3)
- Sa1933 Safety of Immunomodulators and Anti-TNF Drugs for the Treatment of Inflammatory Bowel Disease (IBD) During Pregnancy (2011) (2)
- Immigrant IBD Patients in Spain Are Younger, Have More Extraintestinal Manifestations and Use More Biologics Than Native Patients (2022) (2)
- P408 Safety of immunomodulators and anti-TNF drugs for the treatment of inflammatory bowel disease (IBD) during pregnancy (2012) (2)
- Meta-Analysis: Rabeprazole and Esomeprazole in the Eradication of Helicobacter pylori (2011) (2)
- Patient-Evaluated Quality of Care is Related to Better Inflammatory Bowel Disease Outcomes: The IQCARO II Project (2021) (2)
- Su1175 Fourth-Line Rescue Therapy With Rifabutin in Patients With Three H. pylori Eradication Failures (2014) (2)
- TEO-Transanal Intersphincteric Intramesorectal and Laparoscopic Approach in Proctosigmoidectomy for Benign Disease (2019) (2)
- W1309 Efficacy of Adalimumab in the Treatment of Ulcerative Colitis (2010) (2)
- M1141 Infliximab Maintenance Therapy Decreases the Use of Non-Pharmacological Resources in Patients with Crohn's Disease (2008) (2)
- Esophagitis in a High H. pylori Prevalence Area: Severe Disease Is Rare but Concomitant Peptic Ulcer Is Frequent (2011) (2)
- [Seven or ten days? Cost-effectiveness study on the duration of H. pylori treatment in primary care]. (2006) (2)
- Clinical usefulness of lanthanum carbonate for serum phosphate control in difficult patients (2012) (2)
- [Management of acute lower gastrointestinal hemorrhage: position statement of the Catalan Society of Gastroenterology]. (2013) (2)
- Factors associated with quality of care in inflammatory bowel diseases: a view from patient’s side using the IQCARO quality of care decalogue (2021) (2)
- P289 Evaluation of the safety and effectiveness of direct-acting antiviral drugs in the treatment of hepatitis C in patients with inflammatory bowel disease: National multicenter study (ENEIDA registry). MIC project (2022) (2)
- Knowledge of disease and access to a specialist reported by Spanish patients with ulcerative colitis. UC-LIFE survey. (2017) (2)
- [Endoscopic treatment of bleeding ulcers: has everything been said and done?]. (2005) (2)
- Cólico hepático por paracetamol-codeína (2001) (2)
- H. pylori eradication therapy vs. antisecretory non-eradication therapy (with or without long-term maintenance antisecretory therapy) for the prevention of recurrent bleeding from peptic ulcer. (2004) (2)
- How to compare biologic drugs. (2014) (2)
- Spontaneous regression of hepatocellular carcinoma (1992) (2)
- The Global Incidence of Peptic Ulcer Disease Is Decreasing Since the Turn of the 21st Century: A Study of the Organisation for Economic Co-Operation and Development (OECD) (2022) (2)
- 228 Clinical Judgement Versus Risk Scores for Predicting Outcome in Patients Bleeding from High Risk Peptic Ulcer. Preliminary Results of a Prospective Multicenter Study (2009) (2)
- An optimized clarithromycin-free 14-day triple therapy for Helicobacter pylori eradication achieves high cure rates in Uruguay. (2017) (2)
- Sa1879 Effectiveness of Adalimumab in the Treatment of Perianal Fistulas in Patients With Cronh's Disease NaïVE to Anti-TNF: A Multicenter Study (2012) (2)
- Su1681 Meta-Analysis of Studies Comparing the First and New Generation Proton Pump Inhibitors in the Eradication of Helicobacter pylori (2012) (2)
- Tu1107 Adalimumab Dose Escalation Is Effective for Managing Loss of Response in Ulcerative Colitis (2015) (2)
- [Oesophageal diseases: gastroesophageal reflux disease, Barrett's disease, achalasia and eosinophilic oesophagitis]. (2015) (2)
- W1301 Usefulness of Oral Beclometasone Dipropionate to Induce Remission in Active Ulcerative Colitis Patients: Results From the Reclicu Study (2010) (2)
- P372 Prospective, randomized clinical trial comparing the efficacy of two vaccines against hepatitis B virus (HBV) in inflammatory bowel disease (IBD) patients (2014) (2)
- Outcomes of Peptic Ulcer Bleeding After Treatment With Intravenous Proton Pump Inhibitors in Routine Clinical Practice (2011) (1)
- [Gastric vascular lesions in cirrhosis: gastropathy and antral vascular ectasia]. (2015) (1)
- Su1705 Phase IV, Prospective, Randomized and Comparative Study Between Sequential and Concomitant Therapy for Helicobacter pylori Eradication in Routine Clinical Practice. Interim Results (2012) (1)
- P774 Low adhesion to latent tuberculosis (TB) screening recommendations in inflammatory bowel disease (IBD) patients: Results of the INFEII registry of GETECCU (2020) (1)
- P275 Clinical characteristics, associated malignancies and management of primary sclerosing colangitis in inflammatory bowel disease patients: A Spanish nationwide study based on the ENEIDA registry (2018) (1)
- DOP22 Certification of integral care IBD Units: Evaluation of a certification program (CUE) (2020) (1)
- [Endoscopic ligation with elastic bands in the prevention of hemorrhage recurrence caused by esophageal varices. Study of 45 patients]. (1996) (1)
- Second-Line Rescue Therapy With Levofloxacin After H. pylori Treatment Failure. Time Trends of Eradication in a Spanish Multicenter Study of 830 Patients (2011) (1)
- P042 The effect of infliximab and adalimumab treatment on angiogenic factor levels in patients with inflammatory bowel disease (IBD) (2012) (1)
- P607 Post-operative mortality and predictive factors in a cohort of severe refractory ulcerative colitis patients from the ENEIDA Registry (1989-2013): a multicenter nationwide study. (2017) (1)
- Oesophageal disease: gastroesophageal reflux disease, Barrett's oesophagus, achalasia and eosinophilic oesophagitis. (2016) (1)
- P776 Factors associated with quality of care perceived by patients in IBD units from Spain. Analysis from IQCARO project (2019) (1)
- What is the best first-line therapy for Helicobacter pylori infection? (2008) (1)
- UTILITY OF SHOCK INDEX FOR RISK STRATIFICATION IN ACUTE LOWER GASTROINTESTINAL BLEEDING (2020) (1)
- OP20 Risk and predictors of surgery in a newly diagnosed cohort of IBD patients in the biologic era: Results from the EpidemIBD study (2021) (1)
- Comparative efficacy of different proton pump inhibitors in triple therapy for Helicobacter pylori eradication: A meta-analysis (2003) (1)
- P104 - Safety and efficacy of adalimumab in a patient with refractory Crohn's disease and previous severe infliximab hepatotoxicity. A case report (2009) (1)
- Costs of Managing Helicobacter pylori‐Infected Ulcer Patients After Initial Therapy (2002) (1)
- Immune thrombocytopenic purpura associated with Crohn's disease with complete response to infliximab (2019) (1)
- P424 Is the switch to a second thiopurine a safe strategy in elderly patients with inflammatory bowel disease? A multi-centre cohort study of the ENEIDA registry (2019) (1)
- DOP018 Low microbial diversity in Crohn's disease is due to striking depletion of unknown species (2014) (1)
- Update on the management of Helicobacter pylori infection. Position paper from the Catalan Society of Digestology (2018) (1)
- P437 Risk of immunomediated adverse events or secondary loss of response to infliximab in elderly patients with inflammatory bowel disease: a cohort study of the ENEIDA registry (2019) (1)
- [Social and work coverage in chronic diseases: disability]. (2007) (1)
- Corrigendum: Prevalence and Factors Related to Hepatitis B and C in Inflammatory Bowel Disease Patients in Spain: A Nationwide, Multicenter Study (2009) (1)
- Esophageal, Gastric and Duodenal Disorders / Helicobacter pylori: Diagnosis, Treatment and Antimicrobial ResistanceEradication of Helicobacter pylori for the Prevention of Peptic Ulcer Rebleeding. Long-Term Follow-up Study of 890 Patients (2011) (1)
- [Esophageal diseases: gastroesophageal reflux disease, Barrett's esophagus and eosinophilic esophagitis]. (2011) (1)
- P761 Healthcare quality assessment in inflammatory bowel disease Units in Spain under patient’s perspective. IQCARO project (2019) (1)
- Long-term outcomes of biological therapy in Crohn's disease complicated with internal fistulizing disease: BIOSCOPE study from GETECCU. (2021) (1)
- P397 Effectiveness of vedolizumab (VDZ) for the induction of remission in inflammatory bowel disease (IBD): Results from the Spanish Eneida Registry (2018) (1)
- P232 IQCARO project: A decalogue to improve quality of care through patient′s eyes (2018) (1)
- Detection of Helicobacter pylori Microevolution and Multiple Infection from Gastric Biopsies by Housekeeping Gene Amplicon Sequencing (2020) (1)
- EFFECT OF WEEKEND HOSPITAL ADMISSION ON LOWER GASTROINTESTINAL BLEEDING OUTCOMES (2020) (1)
- [Use of intravenous iron infusion in a gastroenterology day hospital: Indications, dosage and adverse effects]. (2010) (1)
- Optimum second-line regimens for Helicobacter pylori eradication (2014) (1)
- Sa1117 Extracolonic Neoplasias in Inflammatory Bowel Disease Patients: Data From the GETECCU Eneida Registry (2015) (1)
- Tu1285 Endocopist's Clinical Judgment vs. Scoring Systems in Predicting Outcome in Bleeding Peptic Ulcer. Results of a Prospective and Multicenter Study (2013) (1)
- Real-World Evidence of Tofacinitib in Ulcerative Colitis: Short-Term and Long-Term Effectiveness and Safety. (2023) (1)
- Rapid Identification of Viable H. pylori Cells in Feces by DVCFISH (2015) (1)
- M1973 High Prevalence of Human Papillomavirus in a Spanish Population with Esophageal Cancer (2009) (1)
- Sa2027 Risk of Colectomy in Patients With Ulcerative Colitis Under Thiopurine Treatment. Study of Prevalence and Predictive Factors. Eneida Project (2012) (1)
- [Helicobacter pylori eradication. Triple or quadruple therapy?, Long or short treatment?]. (2003) (1)
- P025 - Patient preferences for Crohn's disease maintenance therapy: a discrete choice experiment (2009) (1)
- A randomized controlled trial of the efficacy of two weeks of omeprazole and clarithromycin vs. one week of omeprazole, clarithromicin and amoxicillin for cure of Helicobacter pylori infection in primary care: Preliminary results* (1998) (1)
- P606 Phenotypic characteristics and use of therapeutic resources in elderly-onset inflammatory bowel disease: A multicentre, case-control study (2014) (1)
- P743 Time trends of Crohn’s disease in Catalonia from 2011 to 2017. Increasing use of biologics correlates with a reduced need for surgery. A population-based study in Catalonia (2020) (1)
- Comparable Quality of Bowel Preparation With Single‐Day Versus Three‐Day Low‐residue Diet: A Randomized Controlled Tria (2020) (1)
- Su1684 Rifabutin in the Treatment of Refractory Helicobacter pylori Infection: A Review (2012) (1)
- Mo1740 Prospective, Randomized Clinical Trial Comparing the Efficacy of Two Vaccines Against Hepatitis B Virus (HBV) in Inflammatory Bowel Disease (IBD) Patients (2014) (1)
- Mo1860 REAL-WORLD LONG-TERM EFFECTIVENESS OF USTEKINUMAB IN CROHN'S DISEASE: RESULTS FROM THE ENEIDA REGISTRY (2020) (1)
- Correction: Impact of treatment with direct-acting antivirals on anxiety and depression in chronic hepatitis C (2020) (1)
- Is acute hepatic necrosis a cause of hyperkalemia? (1987) (1)
- Is Helicobacter pylori infection is a risk factor for hepatic encephalopathy (1998) (1)
- Risk of infection associated with Janus Kinase (JAK) inhibitors and biological therapies in inflammatory intestinal disease and rheumatoid arthritis. Prevention strategies (2021) (1)
- Quality of life during one year of postoperative prophylactic drug therapy after intestinal resection in Crohn's patients: Results of the APPRECIA trial. (2019) (1)
- Treatment of Helicobacter pylori infections (1998) (1)
- Gastroenterologists’ attitudes on the detection and management of gastric premalignant conditions: results of a nationwide survey in Spain (2020) (1)
- Effects of a multidisciplinary approach on the effectiveness of antiviral treatment for chronic hepatitis C. (2016) (1)
- P443 Clinical features, therapeutic requirements, and evolution of patients with Crohn's disease and upper digestive tract involvement (CROHNEX study) (2019) (0)
- Proton pump inhibitor‐based triple therapies versus dual therapies for Helicobacter pylori eradication (2013) (0)
- Correction to: Efficacy and safety of endoscopic balloon dilation in inflammatory bowel disease: results of the large multicenter study of the ENEIDA registry (2019) (0)
- EFFECTIVENESS AND SAFETY OF THE SEQUENTIAL USE OF A SECOND AND THIRD ANTI-TNF AGENT IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: RESULTS FROM THE ENEIDA REGISTRY SHORT TITLE: Sequential use of anti-TNFs in IBD patients AUTHORS (2020) (0)
- Do proton pump inhibitors increase the risk of myocardial infarction (2016) (0)
- [Prognostic factors of early mortality in the 1st episode of hemorrhage caused by esophageal varices]. (1996) (0)
- OP17 Risk of colectomy in patients with ulcerative colitis under thiopurine treatment. Study of prevalence and predictive factors. ENEIDA project (2012) (0)
- What Is the Best Strategy for Diagnosis andTreatment of Helicobacter pylori in the Prevention of Recurrent Peptic Ulcer Bleeding ? A Cost-Effectiveness (2010) (0)
- Sa1741 The Antrum and Corpus mRNA and Small-RNA Profile of the Human Healthy Stomach (2015) (0)
- Quality in diagnostic upper gastrointestinal endoscopy for the detection and surveillance of gastric cancer precursor lesions: Position paper of AEG, SEED and SEAP (2021) (0)
- T1094 The Changing Face of Hospitalizations Due to Gastrointestinal Complications (2009) (0)
- P634 Ustekinumab and vedolizumab as first-line biological therapy for inflammatory bowel disease. A multicenter study based on the ENEIDA registry (2023) (0)
- Su1167 European Registry on H. pylori Management (Hp-EuReg): Spanish Detailed Results (Interim Analysis) (2014) (0)
- The Expression of mir-19b-3p and HIPK3 is Highly Correlated in Patients with Precancerous Lesions of Gastric Cancer (2017) (0)
- Prevalence of Helicobacter pylori resistance after failure of first-line therapy. A systematic review (2018) (0)
- Correction: Chaparro et al. Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological Study. J. Clin. Med. 2021, 10, 2885 (2022) (0)
- To test or not to test. Usefulness of Helicobacter pylori determination after triple therapy in uncomplicated duodenal ulcers. A cost-effectiveness analysis (2000) (0)
- Knowledge of disease and access to a specialist reported by Spanish patients with ulcerative colitis. UC-LIFE survey. (2017) (0)
- S1108 Hepatitis B and C Reactivation in Inflammatory Bowel Disease Patients Treated with Immunosuppressive Therapy. A Nationwide Multicenter Study (2009) (0)
- UEG Week 2015 Oral Presentations (2015) (0)
- P041 Infliximab Impact on the Use of Health Care Resources among Patients with Crohn's Disease in Clinical Practice Conditions (2008) (0)
- [Esophageal diseases: gastroesophageal reflux disease and Barrett's esophagus]. (2012) (0)
- Sa1260 Durability of the anti-HBs Titers After Vaccination Against Hepatitis B Virus (HBV) in Patients With Inflammatory Bowel Disease (IBD) (2015) (0)
- P643 Psoriasis induced by anti-TNF therapy in Inflammatory Bowel Disease: analysis of therapeutic management and evolution of both diseases in a nationwide cohort study (2023) (0)
- ON002 Efficacy of nurse-driven outpatient clinic for follow-up of inflammatory bowel disease patients on treatment with thiopurinic immunosuppresants (2012) (0)
- S1165 Unexpected Follow-Up Surgeries Related to Failures in Colectomy for Ulcerative Colitis (2009) (0)
- Pancreatic pseudocyst secondary to chemotherapy for acute lymphoblastic leukaemia: successful percutaneous drainage. (1992) (0)
- M1959 Epidemiological Characteristics of Barrett's Esophagus in Spain (2008) (0)
- Multicriteria Decision Analysis for Updating of Quality Indicators for Inflammatory Bowel Disease Comprehensive Care Units in Spain (2022) (0)
- [Esophageal diseases: gastroesophageal reflux disease, Barrett's esophagus, achalasia and eosinophilic esophagitis]. (2011) (0)
- Prospective, study comparing the accuracy of two different stool antigen tests (Premier Platinum HpSA and novel ImmunoCard STAT! rapid test) for the diagnosis of Helicobacter pylori infection (2020) (0)
- M1126 Effectiveness of a 10-Day Triple Therapy Combining Potent Acid Inhibition With Amoxicillin and Metronidazole for H. pylori Eradication in Clinical Practice. A Pilot Study (2010) (0)
- P826 Economic impact of inflamatory bowel disease in Catalonia. A population-based analysis (2023) (0)
- Proton pump inhibitors (PPI), clarithromycin (C) and amoxicillin (A) or a nitroimidazole (N) for one week. A meta-analysis of its efficacy on H. pylori eradication (2000) (0)
- Generalidades sobre Helicobacter pylori (2006) (0)
- P078 - Patient preferences for Crohn's disease flare-up therapy: a discrete choice experiment (2009) (0)
- [Dyspepsia, Helicobacter pylori and endoscopy]. (2000) (0)
- [Acid-related diseases. What is the current rescue treatment of choice for Helicobacter pylori: quadruple therapy (proton pump inhibitor, bismuth, tetracycline and metronidazole) or triple therapy with proton pump inhibitor, amoxicillin and levofloxacin?]. (2008) (0)
- Efficacy of Continuous Salivary Aspiration to Improve Upper Gastrointestinal Endoscopy Tolerance: A Prospective Randomized Study (2005) (0)
- Effects of a multidisciplinary approach on the effectiveness of antiviral treatment for chronic hepatitis C. (2016) (0)
- Su1130 Second-Line Rescue Therapy With Levofloxacin After Failure of Treatment to Eradicate Helicobacter pylori Infection: Time Trends in a Spanish Multicenter Study of 1,500 Patients (2014) (0)
- P778 Effectiveness and safety of a second-line rescue therapy for acute severe ulcerative colitis refractory to infliximab or ciclosporin (REASUC study) (2023) (0)
- Tu1886 The Effect of Infliximab and Adalimumab Treatment on Angiogenic Factor Levels in Patients With Inflammatory Bowel Disease (IBD) (2012) (0)
- [Not Available]. (2005) (0)
- Disease severity infamilial casesofIBD (2014) (0)
- DOP78 Comparative study of the effectiveness of vedolizumab versus ustekinumab after anti-TNF failure (VERSUS-CD) (2022) (0)
- [Efficacy of laparoscopy in the diagnosis of ascites of indeterminate origin]. (1988) (0)
- P537 Real-world long-term effectiveness of ustekinumab in Crohn’s disease: Results from the ENEIDA registry (2020) (0)
- [Cecal cytomegalovirus infection following appendicectomy in a patient with ulcerative colitis]. (2005) (0)
- P605 Development and validation of an objective disability index for Inflammatory Bowel Disease patients (ODIBD) (2021) (0)
- Pancreatic Endoscopic-Percutaneous Rendezvous Through Jejunostomy for Treating Complex Pancreatic Postsurgical Fistula (2005) (0)
- P186 Association between anti-TNF serum levels and mucosal healing in inflammatory bowel disease. (2017) (0)
- Inverse Correlation of Pleckstrin mRNA and miR-200a in the Antrum of Helicobacter Pylori Infected Patients (2017) (0)
- S1168 Postcolectomy Burden in Ulcerative Colitis Patients Undergoing Colectomy (2009) (0)
- PG135 PATIENT PREFERENCES FOR CROHN'S DISEASE FLARE-UP THERAPY: A DISCRETE CHOICE EXPERIMENT (2008) (0)
- P544 Comparison of the efficacy of a second intravenous or subcutaneous anti-TNF in the treatment of ulcerative colitis: Real-world data from the ENEIDA registry (2020) (0)
- Heterogeneity in pharmacological treatment and outcomes in Crohn’s disease patients in Catalonia: a population-based observational study (2022) (0)
- P666 Long-term effectiveness and safety of vedolizumab (VDZ) in inflammatory bowel disease (IBD): Results from the Spanish ENEIDA Registry (2018) (0)
- [Helicobacter pylori and gastroduodenal pathology in patient with chronic renal insufficiency undergoing dialysis]. (2002) (0)
- P604 Evaluation of management heterogeneity and complications of Crohn’s disease in Catalonia. A population quality care study (2021) (0)
- [Coordination between primary and specialized care in gastroenterology is insufficient. A survey of gastroenterologists and general practitioners]. (2010) (0)
- Identification of circulating microRNAs for the diagnosis of early-stage gastric cancer. (2017) (0)
- Alpha-fetoprotein in the early diagnosis of hepatocellular carcinoma. (1989) (0)
- 389 Prevalence of Malnutrition and Nutritional Characteristics of Patients With Inflammatory Bowel Disease (IBD) (2016) (0)
- P439 Effectiveness and safety of the sequential use of a second and third anti-TNF agent in patients with inflammatory bowel disease: results from the ENEIDA registry (2019) (0)
- Erratum to "IV Spanish Consensus Conference on Helicobacter pylori infection treatment" <[Gastroenterol Hepatol 39 (2016) 697-721]>. (2017) (0)
- Letters to the EditorRe: peppers at treatment for Helicobacter pylori infection (2000) (0)
- Recommendations for pharmacologic management of IBS with diarrhea (2022) (0)
- P176 Improving quality of care through patient′s eyes: Results from IQCARO project focus groups (2018) (0)
- Survival and prognostic factors in patients with hepatocellular carcinoma. A multivariate analysis in 211 patients (1989) (0)
- [Triple treatment for the eradication of Helicobacter pylori infection]. (1998) (0)
- [Esophageal diseases: GERD, Barrett, achalasia and eosinophilic esophagitis]. (2014) (0)
- [How to write a medical report for the assessment of disability]. (2014) (0)
- Cyclosporine Treatment For Severe Steroid Refractory Immune-Mediated Colitis In A Patient With Ulcerative Colitis (2023) (0)
- P630 Inflammatory bowel disease in immigrants to Spain: results of the EIIMIGRA study from GETECCU (ENEIDA registry) (2021) (0)
- QUALITY IN DIAGNOSTIC UPPER GASTROINTESTINAL ENDOSCOPY FOR THE DETECTION AND SURVEILLANCE OF GASTRIC CANCER PRECURSOR LESIONS: POSITION PAPER OF AEG, SEED AND SEAP. (2021) (0)
- Genotypic resistanceguided and medication-guided therapies did not differ for eradicating refractory H pylori (2019) (0)
- S1098 Patient Preferences for Crohn's Disease: A Discrete Choice Experiment in Flare-Up and Maintenance Therapy (2009) (0)
- USEFULNESS OF THE MODIFIED ROCKALL INDEX TO PREDICT ADVERSE EVENTS IN UPPER GASTROINTESTINAL BLEEDING DUE TO PEPTIC ULCER (2022) (0)
- M1054 Real-Time PCR Analysis of H. pylori-Negative Paraffin-Embedded Biopsies Reveal Infection in Most Patients with Bleeding Ulcer (2009) (0)
- Systematic review and meta-analysis: triple therapy combining a proton-pump inhibitor, amoxicillin and metronidazole for Helicobacter pylori first-line treatment (2016) (0)
- GLASGOW-BLACHFORD SCORE ACCURATELY PREDICTS THE NEED OF CLINICAL INTERVENTION IN ACUTE LOWER GASTROINTESTINAL BLEEDING. A DIAGNOSTIC ACCURACY EVALUATION STUDY (2019) (0)
- P530 Effectiveness of anti-TNF drugs in Crohn's disease (CD) patients who did not achieve remission with the first anti-TNF (2013) (0)
- Controvèrsies clíniques entorn al tractament de l'Helicobacter pylori (1999) (0)
- Management of non variceal upper gastrointestinal bleeding: Position paper statement of the Catalan Society of Gastroenterology (2017) (0)
- P410 Long-term persistence and safety of biological drugs in patients with Inflammatory Bowel Disease. Differences between women and men: SEXEII study of ENEIDA (2023) (0)
- OAKLAND SCORE IS NOT BETTER THAN HAEMOGLOBIN FOR PREDICTING OUTCOMES IN LOWER GASTROINTESTINAL BLEEDING (2019) (0)
- OP23 Asymptomatic inflammatory bowel disease diagnosed during the colorectal cancer population screening in Catalonia (2023) (0)
- Indications and hemoglobin thresholds for red blood cell transfusion and iron replacement in adults with gastrointestinal bleeding: An algorithm proposed by gastroenterologists and patient blood management experts (2022) (0)
- Cancer Antigen 125 in Serumand AsciticFluidof PatientswithLiverDiseases (1991) (0)
- Sa1223 Phenotypic Characteristics and Use of Therapeutic Resources in Elderly-Onset Inflammatory Bowel Disease: A Multicentre, Case-Control Study (2014) (0)
- P825 The “other burden” of ulcerative colitis: Impact on social and professional life described by Spanish patients (2018) (0)
- [Paracetamol-codeine induced hepatic colic]. (2001) (0)
- Management and long-term outcomes of Crohn's disease complicated with enterocutaneous fistula: ECUFIT study from GETECCU. (2022) (0)
- Su1212 - Droplet Digital PCR Detects an Underdiagnosed Subgroup of Dyspeptic Patients Masked by H.Pylori Low-Density Infection (2018) (0)
- Tu1246 Clinical and Biological Predictors of Fatigue in Inflammatory Bowel Disease Patients (2015) (0)
- P675 Real world evidence of tofacinitib in ulcerative colitis: short and long-term effectiveness, safety and impact of extraintestinal manifestations and immunomediated diseases (2023) (0)
- The incidence of ulcer bleeding post endoscopic band ligation of esophageal varices (2018) (0)
- DOP32 Long-term outcomes of enterocutaneous fistula complicating Crohn’s Disease: The ECUFIT study from GETECCU (2021) (0)
- Risk of infection associated with Janus Kinase (JAK) inhibitors and biological therapies in inflammatory intestinal disease and rheumatoid arthritis. Prevention strategies. (2021) (0)
- Cross-sectional study of human coding- and non-coding RNAs in progressive stages of Helicobacter pylori infection (2020) (0)
- [Do proton pump inhibitors increase the risk of myocardial infarction?]. (2016) (0)
- P830 Motherhood and child care are negatively influenced by ulcerative colitis: patients’ insights from the UC-LIFE survey (2018) (0)
- Alcohol v epinephrine and polidocanol. (1994) (0)
- EFFECT OF A LOW RESIDUE DIET DURING ONE DAY VERSUS THREE DAYS ON BOWEL CLEANSING, DIET TOLERANCE AND COLONOSCOPY PERFORMANCE: A NON-INFERIORITY RANDOMISED CLINICAL TRIAL (2020) (0)
- Recommendations for pharmacologic management of IBS with constipation (2022) (0)
- Mo1088 Evaluation of Symptomatic Burden of Ulcerative Colitis and Satisfaction With Treatments by Spanish Patients. UC-Life Survey (2015) (0)
- [New data on the efficacy of proton pump inhibitors in upper gastrointestinal bleeding]. (2010) (0)
- Heterogeneity of clinical management of low-grade gastric lymphoma of mucosa-associated lymphoid tissue. An audit of 198 patients in Spain. (2019) (0)
- Validation of a self-reported work disability questionnaire for ulcerative colitis (2018) (0)
- Surgical resection improves survival in cirrhotics with asymptomatic hepatocellular carcinoma (1990) (0)
- Neck "ascites" after peritoneovenous shunt. (1990) (0)
- Tu1276 Validation of a Self-Reported Ulcerative Colitis Work Disability Questionnaire (UCWDQ) (2015) (0)
- P099 - Postcolectomy burden in ulcerative colitis patients undergoing colectomy (2009) (0)
- P290 Therapeutic requirements in patients with Ulcerative Proctitis. Is it necessary immunosuppressive therapy in these patients? (2022) (0)
- Relevance of patient-reported outcome measures (PROM) and patient-reported experience measures (PREM) to assess disease status and quality of care in patients with inflammatory bowel disease. (2023) (0)
- DOP31 Management and outcome of postoperative Crohn’s Disease in the elderly as compared to young adults: Data from Eneida registry (2021) (0)
- Heterogeneity of clinical management of low-grade gastric lymphoma of mucosa-associated lymphoid tissue. An audit of 198 patients in Spain (2020) (0)
- Performance of Screening Strategies for Latent Tuberculosis Infection in Patients with Inflammatory Bowel Disease: Results from the ENEIDA Registry of GETECCU (2022) (0)
- P156 Differential characteristics of patients with inflammatory bowel disease onset in paediatric age compared with patients diagnosed in adulthood: Results from the CAROUSEL study of GETECCU (2018) (0)
- T1198 Prevalence of Hepatitis B (HBV) and C (HCV) in Inflammatory Bowel Disease (IBD): A Transversal Multicentre Spanish Study (2008) (0)
- PG134 PATIENT PREFERENCES FOR CROHN'S DISEASE MAINTENANCE THERAPY: A DISCRETE CHOICE EXPERIMENT (2008) (0)
- Coding and non-coding co-expression network analysis identifies key modules and driver genes associated with precursor lesions of gastric cancer. (2022) (0)
- FEASIBILITY OF UNRESTRICTED DIET VERSUS A 3-DAY LOW-RESIDUE DIET PRE-COLONOSCOPY AND IT IMPACT ONTHE QUALITY OF THE BOWEL PREPARATION (2022) (0)
- 139 Development and Validation of the Crohn's Disease Perceived Disability Questionnaire (CPDQ) (2009) (0)
- Plasma sample based analysis of gastric cancer progression using targeted metabolomics (2017) (0)
- [Prescribing antiinflammatory drugs]. (2009) (0)
- Generalities about Helicobacter pylori (2006) (0)
- P654 Clinical outcomes in familial versus sporadic inflammatory bowel disease diagnosed in the era of biological therapies. Prospective data from the ENEIDA registry (2022) (0)
- M1134 Criteria for Awarding Disability Benefits to Crohn's Disease Patients: A Study of Cases in Spanish Case Law (2009) (0)
- COMPLEX ANTITHROMBOTIC THERAPY IN PATIENTS WITH ACUTE LOWER GASTROINTESTINAL BLEEDING: CLINICAL OUTCOMES (2020) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Xavier Calvet?
Xavier Calvet is affiliated with the following schools:
